
|Articles|January 1, 2004
Spring launch planned for Allergan's epinastine
Irvine, CA-Allergan plans to launch epinastine (Elestat), an ophthalmic antihistamine it has licensed for ophthalmic uses, during the first quarter of 2004.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















